Jill Fallows Macaluso Esq., RN, has been Corporate Vice President and
Chief Compliance Officer for Novo Nordisk Inc. since January 2018 and
has been leading the US Compliance Program since being appointed Vice
President and Chief Compliance Officer in September 2015. Jill is
responsible for safeguarding corporate governance and integrity
practices in the United States while upholding the company's
commitment to operate according to the highest ethical standards of
business conduct as part of the Novo Nordisk Way. She is also the
Executive Sponsor for the EMERGE Employee
Resource Group for Millennials, which aims to leverage the
energy and influence of early career professionals to drive Novo
Nordisk's purpose to defeat diabetes and other serious chronic conditions.
With 15 years of industry experience, Jill has been instrumental in
evolving Novo Nordisk's compliance program to support industry leading
business practices. By serving as a corporate compliance partner, she
has spearheaded efforts focused on rebranding and operational
efficiency. As chair of the Executive Ethics & Compliance
Committee, she plays an active role ensuring compliance is
incorporated into company decision-making processes.
Jill joined Novo Nordisk in 2003 and held several positions of
escalating responsibility with in the Legal Team for nine years
including Senior Corporate Counsel. She transitioned to the Compliance
Department as Senior Director in 2012.
Previously, Jill was with the General Corporate and Healthcare
practice of Day Pitney, LLP. She holds a Bachelor of Science in
Nursing from the University of Pennsylvania and a Juris Doctorate from
Rutgers University School of Law.